[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Longeveron Inc (LGVN)

Longeveron Inc (LGVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Longeveron Inc 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 USA

https://longeveron.com Employees: 38 P: 305-909-0840

Sector:

Medical

Description:

Longeveron Inc. is a clinical stage biotechnology company. It engages in developing cellular therapies for chronic aging-related and life-threatening conditions. The company's investigational product includes LOMECEL-B(TM). Longeveron Inc. is based in MIAMI.

Key Statistics

Overview:

Market Capitalization, $K 21,425
Enterprise Value, $K 16,935
Shares Outstanding, K 3,188
Float, K 2,952
% Float 92.58%
Short Interest, K 1,555
Short Float 4.99%
Days to Cover 7.29
Short Volume Ratio 0.49
% of Insider Shareholders 7.42%
% of Institutional Shareholders 10.01%

Financials:

Annual Sales, $ 1,200 K
Annual Net Income, $ -22,700 K
Last Quarter Sales, $ 290 K
Last Quarter Net Income, $ -6,070 K
EBIT, $ -23,660 K
EBITDA, $ -22,430 K

Growth:

1-Year Return -19.03%
3-Year Return -97.45%
5-Year Return -98.20%
5-Year Revenue Growth -78.69%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 08/12/26
Next Earnings Date 11/03/26
Earnings Per Share ttm -0.99
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 42.42%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 08/27/26

LGVN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -223.19%
Return-on-Assets % -150.20%
Profit Margin % -1,891.67%
Debt/Equity 0.00
Price/Sales 18.08
Price/Cash Flow N/A
Price/Book 2.07
Book Value/Share 0.33
Interest Coverage -0.88
60-Month Beta -0.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.